Clinical Trial Supply Europe 2023

Biography: For more than 30 years at SANOFI in R&D, David developed a dual competency in the Information system architecture first and now in Clinical supply chain. Currently he is leading processes, solutions, and innovations department. He is in charge to implement the new ERP solution, responsible of IRT strategy and development of innovation like e-labeling.

Session Details: Ask the Expert: Digitalisation, Automation and Patient Centricity – Where does it all fit? 23-03-2022, 8:30 am View In Agenda

Biography: Arnaud Dourlens is an Arts et Métiers engineer, he began his industrial career in the FMCG sector where he held growing responsibilities. Then he joined the LVMH group where he reorganized new product launches and industrial investments in the Make-up segment in order to adapt to the need for innovation and time to market, thus providing a competitive advantage. He then managed the entire portfolio of industrial launches and investments in Perfumes, Skincare and Make-up for Parfums Christian Dior Group. During his career Arnaud held a wide variety of industrial roles. He joined Sanofi in 2017 as Production Director of a major solid oral form production site (>2.5 billion € turnover). He has been a key player in the development of the continuous improvement mindset and in the transformation of the site through IT projects, investments and activity growth following the acquisition of Boehringer Ingelheim consumer healthcare portfolio. Since the beginning of 2020, he’s been the global head of Sanofi Clinical Supply Chain Operations, managing worldwide clinical supply teams involved in more than 300 clinical studies.

Session Details: Keynote Address: The Reality Of the ‘Post-Covid Era’ Clinical Trials: Considering Innovation at Every Stage Across Your Supply Lifecycle 22-03-2022, 8:30 am FIRESIDE CHAT: Importance of DTP for future trials 22-03-2022, 11:00 am View In Agenda

Biography: Marcus has been realizing innovative solutions and clinical science in the Pharma space for almost 20 years. Passionate in driving operational value with technology, the science and the patient is always in focus. As part of AstraZeneca’s Digital Health transformation, he is aiming to bring greater value to patients faster though technology. Marcus is gearing up AstraZeneca’s capabilities to take on De-centralized trials, with patient centricity at heart.

Session Details: FIRESIDE CHAT Exploring Home Supply in the DCT context: Are Decentralized Trials the Answer? 22-03-2022, 11:00 am PANEL DISCUSSION Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm PANEL DISCUSSION: Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm View In Agenda

Biography: Courtney Soulsby works as a Global Director for the Healthcare and Life Sciences sector team for BSI (British Standards Institution). Working to understanding market challenges and future needs of the healthcare sector, Courtney works with key clients and industry partners to develop holistic solutions, strategies and programs. Courtney has worked with pharmaceutical industry and their downstream logistics supply chain for over ten years – with a deep understanding the issues with regulation, compliance, quality, and other risk exposures when transporting medicines.

Session Details: FIRESIDE CHAT Future-Proofing your Supply Chain Through Implementation of a Sustainable Serialisation Strategy 22-03-2022, 3:00 pm View In Agenda

Biography:

Session Details: CASE STUDY: Direct-to-Patient Shipments in Orphan Drug Trials and How to Navigate Hurdles to Deliver Drugs Safely and Efficiently 22-03-2022, 9:30 am View In Agenda

Biography: Francisco (52) is a certified Non-Executive Director, Economic Analyst & MBA with 28 years of experience in International Trade & Air Freight Transportation, specialized on Temperature Controlled Shipments of Pharmaceuticals. Currently, at the International Air Transport Association (IATA) holding the position of Cargo Specialist Manager for the EU, UK, Turkey, Ukraine, Israel, Russia & CIS countries being responsible for delivering IATA’s Cargo Agenda in the Region and supporting the air cargo industry adoption and implementation of IATA´s global certification program for the proper air transportation of pharmaceuticals: being Instructor for the IATA’s Diploma of Air Cargo Transportation of Pharmaceuticals including courses of Temperature Control Risk Management, Temperature Control Air Cargo Operations, Audit and Quality for Temperature Controlled Shipments with more than 350 trained industry professionals globally. Additionally acting also as IATA`s Auditor & Consultant on pharma temperature control projects at Airports in Europe, US, Canada, Latin America and South Africa for Airlines, Airports´ Handling & Ramp Operators, Freight Forwarding Companies and Trucking Companies. Before joining IATA, Francisco owned and managed his own company for 15 years dedicated to Freight Forwarding, Customs Brokerage and Int´l Trade Consulting, and worked for companies like Panalpina and UPS (Supply Chain).

Session Details: Airfreight Temperature Controlled Logistics for Clinical Trials & Pharma Products 22-03-2022, 12:00 pm View In Agenda

Biography: Jennifer C. Smith is Senior Editor for GlobalData’s investigative, science journalism team based in New York and London. An award-winning healthcare journalist with a deep knowledge of the US and European pharmaceutical, regulatory and pricing/reimbursement sector, Jennifer works closely with other management on editorial strategy and output, mentors and trains junior reporters and is responsible for wide-ranging editorial projects. Her passion for healthcare and science-related news, with a particular focus on government and public and social policy, has led to diverse reporting experience across the US and internationally over the past decade.

Session Details: Navigating distribution challenges for rare disease drugs 22-03-2022, 12:00 pm PANEL DISCUSSION Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm PANEL DISCUSSION: Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm ROUNDTABLES 23-03-2022, 3:30 pm View In Agenda

Biography: Ignacio joined Janssen in 2014 as part of the GOLD Program.  He completed 3 international rotations as a Drug Product Demand Planner, Process Engineer, and SAP Master Data Team Lead.  Subsequently Ignacio became the JIT (Just-in-Time) Team Lead while working as a Staff Engineer Tech. Development & Innovation. Driven by curiosity and willingness to help others, Ignacio relocated to Nigeria for 6 months to work for a Maternal and Newborn Health NGO under J&J’s Secondment Program. Shortly after his return, Ignacio joined the CAR-T Systems Group to help deploy end-to-end tools for new emerging modalities within the Biotherapeutics Clinical Supply Chain.  

Session Details: New Modalities and Their Supply Chain Challenges. CAR-T & Radiopharmaceuticals 22-03-2022, 4:00 pm New Modalities and Their Supply Chain Challenges. CAR-T & Radiopharmaceuticals 22-03-2022, 4:00 pm View In Agenda

Biography: Hadar owns B.Sc. in Chemical engineering From BGU (Ben-Gurion University of the Negev) & B.Sc. in Polymer engineering from Shankar College of Engineering experienced in leading R&D projects in Biopharmaceutical companies. Worked in Perrigo API performing commercial procurement for the API division, joined Teva in 2011 as Senior procurement manager in R&D performing global procurement. Since joining Clinical Supply Chain group,  within TEVA's R&D global clinical operations in 2018, Hadar been leading clinical supply chain projects within verity of programs and TAs, each one includes multiple clinical trials in different clinical phases, identifying unique challenges and tailoring the project planning accordingly with ongoing risk management in accordance with international guidelines and regulations. She holds various responsibilities including plan efficient drug product demands, coordinating the manufacturing with CMC in all TEVA's manufacturing plants, sourcing of comparators, plan and design the clinical drug packaging and labeling, Design IRT/RTSM system, set-up and oversee maintenance and overall ensure timely delivery within specifications, quality and standards. Hadar initiated and led new approach for P&L at Teva, and manage the first large scale 'Direct to patient' (DTP) study, implement also new IRT system to support it.

Session Details: View In Agenda

Biography: Passionate about clinical trial supply chain and clinical trials in general, Bernard started in a Phase I Clinic, developing analytical methods and combining both his Chemistry & Pharmaceutical degrees. After that it was 25 years of anything touching clinical trial supply chain: starting in an IRT department, then moving to a manufacturing environment, followed by outsourcing, heading a global clinical supplies unit of a Big Pharma company, 2 years as QA, and finally started 14 years ago at PPD, now part of Thermo Fisher Scientific. At PPD, part of Thermo Fisher Scientific, Bernard started on the operational side, but is now on the support side, ensuring the department is ready for growth, from an improvement, compliance & resource perspective

Session Details: Big Data & Systems for our Own Internal Supply Chain – Our People 22-03-2022, 3:00 pm PANEL DISCUSSION Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm PANEL DISCUSSION: Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm View In Agenda

Biography: After graduating in business management, Thierry Gillard has been involved in logistics and supply management for over 20 years. He made his first step in clinical packaging and distribution in 2007 with a major CMO involved worldwide in clinical supplies management. During 10 years with this CMO, he has been contributing to the set-up of a wide array of clinical studies and packaging designs from phase I manually distributed studies, to large Phase III IRT controlled studies, including supply forecasting and Campaigns management. As a Senior Clinical Supplies Manager for Santhera Pharmaceuticals in Switzerland since 2017, a company specializing in neuro-ophthalmological, neuromuscular und pulmonary conditions, widely relying on external vendors, he is in charge of the selection, qualification and oversight of CMO’s providing clinical packaging, distribution and IRT services.

Session Details: Optimising Communication between Sponsors and Vendors to Allow for an Efficient Supply Operation without Delays and Financial Loss 23-03-2022, 9:30 am ROUNDTABLES 23-03-2022, 3:30 pm View In Agenda

Biography: John Shillingford, PhD is an experienced clinical researcher whose career in the Pharmaceutical, Medical Device and CRO industries has stretched over 40 years.  John has both lived and worked in a number of European Countries as well as the USA.   He is now lives in Germany. His wide experience of Drug and Medical Device Development in Europe and the USA has been acquired during the management of both Clinical and Data Operations for major Global Programmes. John has held senior positions in Management, Clinical Operations and Project Management for, Aptiv Solutions, Averion International (a Medical Device Research Company), PRA International and Imform GmbH. Currently John is Clinical Operations Director and a member of the Board of Afon Technology Ltd, a UK based Medical Device Company, Consultant to International Research Companies  and additionally continues to run a number of training courses in Vendor and Project Management.

Session Details: Conflict Resolution between Trial Sponsors and CROs 23-03-2022, 2:00 pm View In Agenda

Biography:

Session Details: View In Agenda

Biography: Vanessa is the MD of Clinical Services International (CSI) a leading provider of Clinical Trial Supplies to the Biopharmaceutical Industry. Vanessa started her career as a research associate at Scotland Yard. Subsequently she worked for leading CROs  and with some of the largest biopharmaceutical and Biotechscompanies to provide innovative solutions. She has extensive experience in drug development from Preclinical to registration and commercialization strategies and has secured product registration for several orphans and first in class drugs. She has a PhD in Cardiovascular Genetics from UCL, an MBA from Cambridge and Masters in Market Access from University m University of Lyon.

Session Details: Chair’s Opening Address 22-03-2022, 8:25 am Clinical Supply Operations Stream 22-03-2022, Comparator Sourcing: An Enabling Step in the Process of Successful Clinical Trials 23-03-2022, 9:00 am View In Agenda

Biography: Marcel Besier has spent the last 20 years of his career in professional services and program management teams working with global clients implementing IT solutions.  As Director of Services Delivery, he oversees the professional services team responsible for project management, account management, and IRT services delivery for Suvoda’s customers in Europe. Marcel holds a dual degree in International Business Administration and General Management.

Session Details: How to Optimize your Trial Supply Chain with a Flexible IRT 22-03-2022, 10:00 am PANEL DISCUSSION Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm PANEL DISCUSSION: Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm View In Agenda

Biography: Amaury Jeandrain has a Master’s Degree in Business Engineering with a specialization in supply chain management. After working for a CRO, he joined N-SIDE where he supported the optimization of hundreds of trials from different indications and pharmaceutical companies, providing services ranging from risk-based optimization to clinical trial design and solving drug supply shortage problems. Amaury now leads a group of consultants, focusing on the extension of N-SIDE’s solutions.

Session Details: Clinical Supply Technology Stream 22-03-2022, Doing More with Less: How Supply and Manufacturing Contribute to Faster Clinical Trial Timelines 22-03-2022, 11:30 am View In Agenda

Biography: Jerome Detreille holds a PhD in Pharmacy and is the Senior Director of New Business Development at PCI. Jerome has over 20 years’ experience in selling services for both conventional and highly potent drugs covering all dosage forms from oral solid dose and drug delivery platforms to sterile injectables. Jerome has held a number of senior positions and prior to joining PCI, he was part of the Executive Team at Penn Pharma and he worked at Catalent Pharma Solutions as Head of European Sales and Business Development for sterile injectables.

Session Details: Too Hard To Handle 22-03-2022, 11:30 am View In Agenda

Biography: David Lorenzo, Business Development Director, joined LSNE (a PCI company) in October 2019 with a strong track record in sales and business development within the pharmaceutical industry. David’s 18+ years of experience span through API and  CDMO sales, licensing and alliance management, with a deep expertise on contract manufacturing of injectable drug products. Prior to joining PCI, David held alliance management and business development positions at Slayback Pharma, Interquim, Chemo and Curia (former companies), where he performed outstanding results in various positions. David studied at the University of Valladolid (Spain) and holds a degree in Organic Chemistry.

Session Details: Too Hard To Handle 22-03-2022, 11:30 am View In Agenda

Biography: Sébastien Coppe has a Master of Engineering in Applied Mathematics. He obtained his PhD by creating a pre-diagnostic tool for patients suffering from Alzheimer’s disease and other kinds of dementia, by designing some mathematical modelling of the patients’ brain behaviour. He is working at N-SIDE where he has been  leading the Life Sciences activities for multiple years, providing services to more than 30 pharmaceutical companies in order to optimize their clinical trial designs and supplies thanks to forecasting and risk-based optimization solutions.

Session Details: Doing More with Less: How Supply and Manufacturing Contribute to Faster Clinical Trial Timelines 22-03-2022, 11:30 am View In Agenda

Biography: Marcus has been realizing innovative solutions and clinical science in the Pharma space for almost 20 years. Passionate in driving operational value with technology, the science and the patient is always in focus. As part of AstraZeneca’s Digital Health transformation, he is aiming to bring greater value to patients faster though technology. Marcus is gearing up AstraZeneca’s capabilities to take on De-centralized trials, with patient centricity at heart.

Session Details: FIRESIDE CHAT Exploring Home Supply in the DCT context: Are Decentralized Trials the Answer? 22-03-2022, 11:00 am PANEL DISCUSSION Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm PANEL DISCUSSION: Navigating the Journey to Decentralised Trials: Establishing a Successful Patient-Centric Clinical Trial Supply Chain Resulting in Enhanced Patient Retention 22-03-2022, 4:30 pm View In Agenda

Biography: Sylvain has acquired extensive experience in IRT through various roles within Calyx over his 10+ years in the company. It allows him to grasp where IRT can make a difference based on the protocol design, and accordingly advise clinical trial teams what solution is the most suitable for each trial. Sylvain is a key member of the Calyx IRT product core team, acting as an advocate for end-users, as well as sharing his vision with the team to push the boundaries of IRT.

Session Details: Will Direct-to-Patient Shipment Shift from Emergency Solution to Routine Practice? 22-03-2022, 12:30 pm View In Agenda

Biography: Iain is an Account Director within Catalent’s Clinical Supply Services and he has worked in clinical trials and clinical drug development since 2010.  Iain has worked with Sponsors, CROs and academic institutions of all sizes supporting them with their early phase clinical studies through to commercialization. Ranging from comparator & commercial drug sourcing to IMP blinding, primary and secondary packaging, global storage and distribution solutions, IMP forecasting, through to clinical supplies management.  Iain has previously worked within Catalent’s global Client Services team undertaking requirements and quotes, working with Catalent’s customers around the globe, from virtual/small biotech and pharma to the larger industry household names. With over a decade of experience within the industry, Iain previously achieved a BSc(Hons) in Biology from the Manchester Metropolitan University in the UK.

Session Details: Essential Building Blocks for a Challenge-Ready, Smart and Responsive Clinical Supply Chain 22-03-2022, 12:30 pm View In Agenda

Biography: Paula Pulsoni is responsible for the operations of the global depot network. Paula is based in Madrid and is responsible for driving continuous improvements and delivering operational excellence network-wide, while focused on bringing value to Clinical Supply Solutions’ clients. Paula earned her pharmacy degree from the University of Buenos Aires. She started her career in World Courier 11 years ago as a depot pharmacist, later on moving into a regional and then global role.

Session Details: Building a Resilient Clinical Trial Supply Chain Through True Logistic Partners 22-03-2022, 2:30 pm View In Agenda

Biography: Stefan has worked in the IRT for 15+ years and has been with Cenduit since its inception in 2007. He worked in various project management roles including leading the global project management team at Cenduit. Stefan currently is responsible for client delivery of key customer accounts and heads the Cenduit drug supply center of excellence. He is very passionate about finding innovative solutions for clinical supply challenges. Stefan holds a master of science in molecular biology and an international executive MBA of the University of St. Gallen

Session Details: Case Study Proofs: How the Implementation of Drug Supply Automation Tools Reduce Waste and Cost 22-03-2022, 2:30 pm View In Agenda

Biography: Nina Nilsson is the Chief Revenue Officer at TSS. With an academic background in medicine at Karolinska Institute in Stockholm, she joined the life science industry in 2005. After 15 years in different International commercial roles, she joined TSS to accelerate the efforts in helping pharmaceutical companies digitize and transform the supply chain to ensure insight-driven, efficient, and sustainable delivery of safe drugs.

Session Details: Opportunities for Automating Temperature Excursion Handling 23-03-2022, 10:00 am View In Agenda

Biography: Dan Pavitt has worked in Information Technology since 2001 specialising in eClinical Solutions since 2006.  A Software Engineer by training, Dan has helped countless clinical teams implement and realise value from a range of eClinical products including Randomisation and Trial Supply Management (RTSM/IRT/IxRS), Electronic Clinical Outcome Assessment (eCOA) and Clinical Trial Management Systems (CTMS) tools.  Dan has worked for a range of Pharma companies and technology vendors, he joined Medidata in 2019 and is currently responsible for the Rave RTSM Solution in Europe.  

Session Details: Simplifying Supply Management to Achieve Efficient Operations 23-03-2022, 11:00 am View In Agenda

Biography: BSc in Pharmacy, MSc in Pharmaceutical Industry and Technology, MSc in Pharmaceutical Biotechnology. Currently studying an Executive MBA. After exploring opportunities in the academia and as community pharmacist I developed my career in the pharmaceutical industry were I have been working for about 12 years, initially in formulation and manufacturing within pharmaceutical development, and during the last 7 years in Clinical Supplies. I have worked for Almirall and AstraZeneca in Spain and for Galderma, Debiopharm and Incyte in Switzerland. I have recently moved back to Spain were I am still working for Incyte within the Global Clinical Supplies group.

Session Details: Q&A with Expert Speaker: How using clinical supply optimization tools can help you improve the communication with your Clinical Study Team 23-03-2022, 11:30 am View In Agenda

Biography: Edo Madussi is the Managing Director, of Euromed Pharma US and Business Unit head of the Clinical Trial Division at the Petrone Group. His business experience combined with his academic background and four spoken languages - English, German, French, and Italian - brought him to develop an extensive network within the global clinical supply chain space.  He is currently developing one of the latest ventures of the Petrone Group: a US-based integrated platform to support Clinical Trial Sponsors and other industry players around the world with a wide range of services in the R&D space.

Session Details: Behind the scenes of Clinical Supplies and Comparators: The latest Regulatory Perspective 23-03-2022, 12:00 pm View In Agenda

Biography: Based in the UK, Chris is responsible for global cell & gene therapy logistics. Since joining Biocair in 2002, Chris has demonstrated Biocair’ s unique client-centric approach by leading teams to deliver in a wide range of challenging situations. He helps meet the complex supply chain needs necessary for commercial distribution of FDA approved therapies

Session Details: Navigating CGT Supply Chain Distributions Now and in the Future 23-03-2022, 1:30 pm View In Agenda

Biography: Ian has over 30 years of pharmaceutical industry experience, predominantly within global organisations such as Pfizer and Eli Lilly.  He built his reputation in the commercialisation of numerous brands in a variety of disease areas, and at every stage of the product lifecycle. During his career, Ian has worked closely with supply chain, ensuring accurate forecasting, and getting medicines to patients through the implementation of novel approaches. Before joining Abacus Medicine Pharma Services Ian worked in senior roles at two leading global clinical solutions companies.  He provided many leading pharmaceutical and biotechnology companies with successful comparator sourcing solutions which helped successfully deliver their pivotal late phase clinical trials.

Session Details: What’s Been Keeping Clinical Supplies Professionals Awake at Night? 23-03-2022, 2:30 pm View In Agenda

Biography: Daniela Duffett is the European Solutions Consultant at Suvoda, based out of our Barcelona office. She consults with clients and prospects, delivering presentations and demonstrations, while acting as a Subject Matter Expert on Suvoda’s solutions. She started at Suvoda three years ago on the Project Management side of our Services Delivery organisation, so can impart her hands-on delivery experience & knowledge.  

Session Details: How to Optimize your Trial Supply Chain with a Flexible IRT 22-03-2022, 10:00 am View In Agenda

Biography: Nicole Haupt-Drescher, Product Manager, Clinical Trial Supplies & Logistics, Parexel, offers a decade of experience managing the organization's activities, operations, and performance for clinical supply management. Nicole has been with Parexel since 2010 and graduated from the University of Tubingen, Germany.

Session Details: The Future Direction of Clinical Trial Supply Chains – What’s Next? 22-03-2022, 9:00 am View In Agenda